Antibodies create broad SARS immune response: study

By The Science Advisory Board staff writers

August 11, 2022 -- Scientists from Scripps Research have discovered certain antibodies are capable of immunity against many different SARS-CoV-2 variants, as well as other SARS viruses like SARS-CoV-1.

Certain animals are more capable of producing these broad antibodies and during their investigation, the study team identified the antibody structures that provide this more comprehensive immune response, which has implications for vaccine production (Science Translational Medicine, August 10, 2022).

Specifically, these neutralizing antibodies recognize a viral spike region that is relatively more conserved or present across SARS viruses and less likely to mutate. In the study, rhesus macaque monkeys were immunized with the SARS-CoV-2 spike protein and two vaccine shots were administered that resemble the current mRNA vaccines available for humans. However, unlike humans, the macaques had a broad neutralizing antibody response against the virus due to their antibodies recognizing the conserved region, in this case the angiotensin converting enzyme 2 receptor binding site.

The majority of human antibodies do not target this region and that suggests additional strategies to coax the human immune system into recognizing this particular region of the virus will be helpful for vaccine production, according to the scientists.

However, the genetics between humans and monkeys differ so more investigation is needed, not only for identifying new strategies against SARS viruses, but also for making sure the best translational models are used.

Copyright © 2022

Create an Account

Already have an account? Sign in Here

To access all ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for

Email Preferences

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.